Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

United Therapeutics reported $104.3M in Stock for its fiscal quarter ending in September of 2023.

Stock Change Date
Amarin USD 228.73M 1.13M Dec/2022
Baxter International USD 2.72B 43M Dec/2022
Bayer EUR 12.79B 1.42B Sep/2022
Biogen USD 2.98B 1.65B Sep/2023
BioMarin Pharmaceutical USD 894.08M 54.62M Dec/2022
Emergent BioSolutions USD 354.3M 13.6M Jun/2023
Esperion Therapeutics USD 35.2M 5.66M Dec/2022
Gilead Sciences USD 3.2B 21M Sep/2023
GlaxoSmithKline GBP 5.15B 487M Dec/2022
Halozyme Therapeutics USD 128.92M 3.48M Sep/2023
Insmed USD 69.92M 3.65M Dec/2022
Intra Cellular Therapies USD 42.99M 1.09M Sep/2023
Ionis Pharmaceuticals USD 25.63M 96K Sep/2023
Moderna USD 487M 228M Sep/2023
Omeros USD 712K 266K Sep/2021
Pfizer USD 8.98B 532M Dec/2022
PTC Therapeutics USD 21.81M 7M Dec/2022
Regeneron Pharmaceuticals USD 2.56B 54.3M Sep/2023
Sarepta Therapeutics USD 244.01M 17.13M Sep/2023
Teva Pharmaceutical Industries USD 3.83B 26M Dec/2022
United Therapeutics USD 104.3M 1000K Sep/2023
Vertex Pharmaceuticals USD 688.7M 85.2M Sep/2023